The creation of retatrutide, a novel dual agonist targeting both GLP-1 and GIP receptors, represents a complex multi-step synthetic process. Initial routes focused on amino acid chain portion coupling, utilizing https://livianbte961095.blog5.net/91813171/production-and-study-implementations-of-retatrutide